KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Return on Invested Capital (2016 - 2025)

Pfizer (PFE) has disclosed Return on Invested Capital for 17 consecutive years, with 0.07% as the latest value for Q4 2025.

  • Quarterly Return on Invested Capital changed N/A to 0.07% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.07% through Dec 2025, changed N/A year-over-year, with the annual reading at 0.24% for FY2025, 65.0% up from the prior year.
  • Return on Invested Capital for Q4 2025 was 0.07% at Pfizer, up from 0.1% in the prior quarter.
  • The five-year high for Return on Invested Capital was 0.43% in Q4 2022, with the low at 0.62% in Q4 2023.
  • Average Return on Invested Capital over 5 years is 0.08%, with a median of 0.07% recorded in 2025.
  • The sharpest move saw Return on Invested Capital skyrocketed 41bps in 2021, then tumbled -48bps in 2023.
  • Over 5 years, Return on Invested Capital stood at 0.41% in 2021, then grew by 4bps to 0.43% in 2022, then tumbled by -245bps to 0.62% in 2023, then skyrocketed by 68bps to 0.2% in 2024, then skyrocketed by 136bps to 0.07% in 2025.
  • According to Business Quant data, Return on Invested Capital over the past three periods came in at 0.07%, 0.1%, and 0.02% for Q4 2025, Q3 2025, and Q2 2025 respectively.